skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

52 studies were found about peginterferon alfa-2a

Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00594880

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00085917

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Condition: HIV Infections

NCT ID: NCT00356486

Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

Condition: Liver Cirrhosis; Hepatitis C Virus; HIV Infection

NCT ID: NCT01006031

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Condition: Hepatitis B; HIV Infections

NCT ID: NCT00391638

Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected Patients

Condition: HIV Infections; Chronic Hepatitis C

NCT ID: NCT00196586

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Condition: Hepatitis C, Chronic; HIV Infections

NCT ID: NCT00553930

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00983853

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00470210

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients

Condition: HIV Infections; Hepatitis C, Chronic; Treatment Failure

NCT ID: NCT00221650

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00612755

Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C

Condition: HIV Infections; Hepatitis C, Chronic

NCT ID: NCT00122616

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01332955

Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

Condition: Chronic Hepatitis B; HIV Infections

NCT ID: NCT00221286

Treatment of Acute Hepatitis C Virus in HIV Co-Infection

Condition: Hepatitis C; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00845676

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00008463

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Condition: HIV Infection; Hepatitis C Infection

NCT ID: NCT00991289

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Condition: HCV-HIV Co-Infection

NCT ID: NCT01725542

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Condition: Chronic Hepatitis C

NCT ID: NCT01513941

Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis C; Liver Disease

NCT ID: NCT00078403

Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00530972

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Condition: Human Immunodeficiency Virus; Chronic Hepatitis C

NCT ID: NCT00909129

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Condition: Hepatitis C Virus Genotype-1

NCT ID: NCT01479868

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00078442

Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and Ribavirin Therapy for Chronic Hepatitis C in Latino Subjects With and Without HIV Co-infection

Condition: Hepatitis C; HIV

NCT ID: NCT01182298

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Condition: Hepatitis C, Chronic

NCT ID: NCT00353418

Treatment of Hepatitis C in Hemophilic Patients With HIV

Condition: HIV Infections; Hepatitis C; Hemophilia

NCT ID: NCT00055341

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Condition: Chronic Hepatitis C

NCT ID: NCT01684787

Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus

Condition: Hepatitis C, Genotype 1

NCT ID: NCT01471574

Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication

Condition: Chronic Hepatitis C; HIV Infections

NCT ID: NCT00296972

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Condition: Hepatitis C

NCT ID: NCT01467479

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Condition: Chronic Hepatitis C; Co-Infection HIV-HCV

NCT ID: NCT00611819

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Condition: Hepatitis C, Chronic; HIV

NCT ID: NCT01925183

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Condition: Hepatitis C Infection; HIV Infection

NCT ID: NCT01185028

A Study to Evaluate Safety and Efficacy of Boceprevir-response Guided Therapy in Controlled HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Condition: HCV and HIV Seropositive Coinfection

NCT ID: NCT01718301

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Condition: Hepatitis

NCT ID: NCT00901524

Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Condition: Hepatitis C; HIV Infections

NCT ID: NCT00132210

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Condition: Hepatitis C; Depressive Disorder, Major; Depressive Disorder; Depression; HIV Infections

NCT ID: NCT00655226

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Condition: HIV; Hepatitis C; Infections

NCT ID: NCT00747539

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Condition: Chronic Hepatitis C

NCT ID: NCT00526448

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

Effects of Low-Dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Condition: Hepatitis C; Liver Cirrhosis; HIV Infections

NCT ID: NCT00381017

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00059358

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Condition: Hepatitis; HIV/AIDS

NCT ID: NCT01443923

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

Condition: Chronic Hepatitis C; Hepatitis C; HIV Infections

NCT ID: NCT00736242

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

Condition: HIV-1 Infection

NCT ID: NCT01935089

Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01482767